0 Comments

New Drug Reverses Symptoms of Deadly Idiopathic Pulmonary Fibrosis

A new drug may cure lung disease idiopathic pulmonary fibrosis (IPF). Developer InterMune reveals that the drug succeeded in significant clinical trials, leading many to believe that the Food and Drug Administration (FDA) will also give the drug its approval. InterMune will officially submit a request to the FDA late this year. “The drug, pirfenidone, […]